Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Clear Cell

Explore clinical trials studying Sarcoma, Clear Cell. Study availability and eligibility vary by location and protocol.

20 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Clear Cell trial results

Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

NCT04593758

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +3 more
Locations
  • City of Hope Duarte, California, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Atrium Health Wake Forest Baptist Winston-Salem, North Carolina, United States
View Trial Details
Completed

Phase 2 Study in Patients With MiT Tumors

NCT00557609

Conditions
Adenocarcinoma, Alveolar Soft Part Sarcoma (ASPS), Carcinoma, +22 more
Locations
  • San Francisco, California, United States
  • Santa Monica, California, United States
  • Miami, Florida, United States
  • Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

NCT02867592

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 142 locations
View Trial Details
Active, Not Recruiting

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

NCT04458922

Conditions
Central Chondrosarcoma, Grade 2, Central Chondrosarcoma, Grade 3, Dedifferentiated Chondrosarcoma, +17 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View all 15 locations
View Trial Details

Related conditions